Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality

OBJECTIVES: The current demographic information from China reports that 10%-19% of patients hospitalized with coronavirus disease (COVID-19) were diabetic. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are considered first-line agents in patients with d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Pharm Assoc (2003)
Main Authors: Stafford, Emma G., Riviere, Jim E., Xu, Xuan, Kawakami, Jessica, Wyckoff, Gerald J., Jaberi-Douraki, Majid
Formato: Artigo
Idioma:Inglês
Publicado em: American Pharmacists Association®. Published by Elsevier Inc. 2020
Assuntos:
Science and Practice
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262497/
https://ncbi.nlm.nih.gov/pubmed/32561317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.japh.2020.05.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados